Pfizer's Mark Brincat joins Exco InTouch to lead its mHealth strategy

Mark Brincat has been appointed product development director at Exco InTouch, a Nottingham, UK-based firm that provides interactive mobile patient communication tools for clinical trials.

He joins the company from Pfizer where he where he spent the last thirteen years managing the delivery of emerging and innovative business technology at Pfizer.

Most recently Brincat served as the pharma company's European healthcare informatics director, working across clinical trials, drug compliance, disease management and 'wellness'.

He also managed the first ever remote patient clinical trial, working with Exco and its mobile diary technology.

In his new role at Exco InTouch Brincat will lead mHealth and mobile product strategy with a particular focus on developing targeted tools for specific therapy areas.

He said: "We all know that healthcare is at a crossroads, so there is no better time to be working with pharmaceutical and healthcare providers to deliver effective and innovative new mHealth solutions directly to patients.”